Managing pseudophakic bullous keratopathy with a topical rho kinase inhibitor: a case series
These findings suggest that Ripasudil has potential as an effective treatment option for PBK, possibly delaying or avoiding the need for corneal transplantation. Further studies are required to confirm the long-term efficacy and safety of Ripasudil for PBK.
Authors
- Nadav Shemesh
- Shani Morad
- Yishay Weill (ORCID: https://orcid.org/0000-0003-4714-2594)
- David Landau (ORCID: https://orcid.org/0000-0003-1770-9086)
- Itay Lavy (ORCID: https://orcid.org/0000-0001-5213-3196)
- Nir Erdinest (ORCID: https://orcid.org/0000-0003-3327-0173)
- Itay Nitzan (ORCID: https://orcid.org/0000-0001-6925-5157)
- David Smadja (ORCID: https://orcid.org/0000-0003-4168-056X)
Institutions
- St George's, University of London (GB)
- Hadassah Medical Center (IL)
- Shaare Zedek Medical Center (IL)
Publication Details
- Journal
- Journal of Medical Case Reports
- Published
- 2025-05-08
- DOI
- https://doi.org/10.1186/s13256-025-05263-6
- Citations
- 3
- Primary Topic
- Glaucoma and retinal disorders
- Type
- article
- Field-Weighted Citation Impact
- 5.12
Funders
- Hebrew University of Jerusalem
- Azrieli Foundation